james smith semaglutide New study shows popular GLP-1 weight loss drug may slow biological aging The Truth About Ozempic: James

Binge-eating disorder in the Swedish national registers: somatic comorbidity

Combining BPC-157 with a proton pump inhibitor in preclinical models could theoretically address both acid suppression and mucosal repair simultaneously

All three patients we discussed had increased residual gastric contents or volume despite following guidelines to stop injectable GLP-1 RA for a week prior to surgery

Multiple-dose pharmacokinetics and pharmacodynamics of n-acetylcysteine in patients with end-stage renal disease

third, a fatty acid side chain is conjugated similar to semaglutide to prolong half-life

Reduces fatigue: Keeps you energized throughout the day